Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Investissement Quebec(IQ)

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon Nov 10, 2023 3:27pm

70 Views

Post# 35729207

RE:Investissement Quebec(IQ)

My issue and others here is this. Those who forget the past are doomed to releat it.

palinc2000 wrote:
Investing is about the future NOT the past!
IQ 's decision came after a 6 month minimum DD..
Did they get in on the cheap? They may have requested THTX to do a Share Consolidation as a pre requisite .Of course legacy shareholders were thrown under the bus with a 50 % dilution at rock bottom pricing...But that is water under the Bridge!
You all can keep lamenting or try to see if there is hope for a substantial share price appreciation in the future.... IQ surely thinks so! They have the benifit of having seen the Business Plan ....Marathon will be dealt with .... somehow
Life is too short to keep looking at the rear view mirror